Abstract | BACKGROUND AND AIMS: METHODS: A total of 166 patients received treatment: 73 (aged <50 years) with active chronic hepatitis and 45 (aged <50) with CHILD hepatic cirrhosis; 24 patients were used as a control group. The first group was treated with alpha-IFN and the second with beta-IFN. RESULTS: The complete response was evaluated at 12 months and the sustained response at 18 months using chi2 according to Yates. Highly significant results (p<0.001) were obtained in the two groups compared to controls, but no statistically significant differences were observed between the various alpha-IFN subgroups. Treatment with alpha-IFN and beta-IFN was effective in reducing indices of cytolysis and viral activities. CONCLUSIONS: IFN treatment positively alters the hepatic histological evolution: the authors affirm that even in advanced cases of chronic liver disease, treatment with IFN may slow down the natural evolution of the disease.
|
Authors | M Spina, D Cioffi, A Ebreo |
Journal | Minerva gastroenterologica e dietologica
(Minerva Gastroenterol Dietol)
Vol. 44
Issue 2
Pg. 117-20
(Jun 1998)
ISSN: 1121-421X [Print] Italy |
Vernacular Title | La nostra esperienza nel trattamento con interferone dell'epatite cronica attiva e della cirrosi epatica HCV correlate. |
PMID | 16495892
(Publication Type: English Abstract, Journal Article)
|